These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1528625)

  • 1. Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates.
    Rayhan R; Xu L; Santarpia RP; Tylenda CA; Pollock JJ
    Oral Microbiol Immunol; 1992 Feb; 7(1):51-2. PubMed ID: 1528625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters affecting the inhibition of Candida albicans GDH 2023 and GRI 2773 blastospore viability by purified synthetic salivary histidine-rich polypeptides.
    Santarpia RP; Cho MI; Pollock JJ
    Oral Microbiol Immunol; 1990 Aug; 5(4):226-32. PubMed ID: 2082248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary anti-candidal assays.
    Santarpia RP; Xu L; Lal K; Pollock JJ
    Oral Microbiol Immunol; 1992 Feb; 7(1):38-43. PubMed ID: 1528623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of pH in salivary histidine-rich polypeptide antifungal germ tube inhibitory activity.
    Brant EC; Santarpia RP; Pollock JJ
    Oral Microbiol Immunol; 1990 Dec; 5(6):336-9. PubMed ID: 2098713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary proteolysis of histidine-rich polypeptides and the antifungal activity of peptide degradation products.
    Xu L; Lal K; Santarpia RP; Pollock JJ
    Arch Oral Biol; 1993 Apr; 38(4):277-83. PubMed ID: 8517799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anti-candidal activity.
    Lal K; Santarpia RP; Xu L; Manssuri F; Pollock JJ
    Oral Microbiol Immunol; 1992 Feb; 7(1):44-50. PubMed ID: 1528624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of salivary factors in persistent oral carriage of Candida in humans.
    Hibino K; Samaranayake LP; Hägg U; Wong RW; Lee W
    Arch Oral Biol; 2009 Jul; 54(7):678-83. PubMed ID: 19439266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the inhibition of blastospore viability and germ-tube development in Candida albicans by histidine peptides and ketoconazole.
    Santarpia RP; Brant EC; Lal K; Brasseur MM; Hong AL; Pollock JJ
    Arch Oral Biol; 1988; 33(8):567-73. PubMed ID: 3075885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans.
    Pollock JJ; Denepitiya L; MacKay BJ; Iacono VJ
    Infect Immun; 1984 Jun; 44(3):702-7. PubMed ID: 6373615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal activity of Turkish honey against Candida spp. and Trichosporon spp: an in vitro evaluation.
    Koc AN; Silici S; Ercal BD; Kasap F; Hörmet-Oz HT; Mavus-Buldu H
    Med Mycol; 2009 Nov; 47(7):707-12. PubMed ID: 19888803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of Candida albicans in human saliva is supported by low-molecular-mass compounds.
    Valentijn-Benz M; Nazmi K; Brand HS; van't Hof W; Veerman EC
    FEMS Yeast Res; 2015 Dec; 15(8):. PubMed ID: 26392045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of saliva composition on growth of Candida albicans and Torulopsis glabrata.
    Lenander-Lumikari M; Johansson I
    Oral Microbiol Immunol; 1995 Aug; 10(4):233-40. PubMed ID: 8602336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5.
    Nikawa H; Jin C; Makihira S; Hamada T; Samaranayake LP
    J Prosthet Dent; 2002 Sep; 88(3):263-7. PubMed ID: 12426495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human salivary histatins: promising anti-fungal therapeutic agents.
    Tsai H; Bobek LA
    Crit Rev Oral Biol Med; 1998; 9(4):480-97. PubMed ID: 9825223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
    Warnock DW; Johnson EM; Burke J; Pracharktam R
    J Antimicrob Chemother; 1989 Jun; 23(6):837-47. PubMed ID: 2547749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey.
    Dagi HT; Findik D; Senkeles C; Arslan U
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of the honeybee products against Candida spp. and Trichosporon spp.
    Koç AN; Silici S; Kasap F; Hörmet-Oz HT; Mavus-Buldu H; Ercal BD
    J Med Food; 2011; 14(1-2):128-34. PubMed ID: 21128826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.